Article Text


Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk
  1. R Estruch1,2,
  2. M A Martínez-González3,
  3. D Corella2,4,
  4. J Basora-Gallisá5,
  5. V Ruiz-Gutiérrez6,
  6. M I Covas2,7,
  7. M Fiol2,8,
  8. E Gómez-Gracia9,
  9. M C López-Sabater10,
  10. R Escoda1,
  11. M A Pena11,
  12. J Diez-Espino3,
  13. C Lahoz12,
  14. J Lapetra2,13,
  15. G Sáez14,
  16. E Ros2,15
  1. 1
    Department of Internal Medicine, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona
  2. 2
    Ciber Fisiopatologia de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III
  3. 3
    Department of Preventive Medicine and Public Health, School of Medicine-Clinica Universitaria, University of Navarra
  4. 4
    Department of Epidemiology, Preventive Medicine and Public Health, School of Medicine, University of Valencia
  5. 5
    Direcció d’Atenció Primària Reus-Tarragona, Institut Català de la Salut, Human Nutrition Unit, School of Medicine, University Rovira i Virgili, Reus (Tarragona)
  6. 6
    Instituto de la Grasa, Consejo Superior de Investigaciones Cientificas, Sevilla
  7. 7
    Cardiovascular Epidemiology Unit, Municipal Institut for Medical Research (IMIM), Barcelona
  8. 8
    Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Palma de Mallorca
  9. 9
    Department of Epidemiology, School of Medicine, University of Malaga
  10. 10
    Department of Nutrition and Bromatology, School of Pharmacy, Barcelona
  11. 11
    Clinical Trial Unit, Fundación LEIA-Hospital Txangorritxu, Vitoria
  12. 12
    Arteriosclerosis Unit, Hospital Carlos III, Madrid
  13. 13
    San Pablo Health Center, Sevilla
  14. 14
    Department of Biochemistry, School of Medicine, University of Valencia
  15. 15
    Lipid Clinic, Endocrinology and Nutrition Service, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain
  1. Dr Ramon Estruch, Dept. of Internal Medicine, Hospital Clinic, Villarroel, 170, 08036 Barcelona, Spain; restruch{at}


Background: Epidemiological studies and feeding trials with supplements suggest that fibre intake is associated with a reduction in cardiovascular risk. However, the effects of changes in dietary fibre on risk factor levels have not been evaluated in free-living individuals. Thus, the effects of changes in dietary fibre intake on cardiovascular risk factors were assessed over 3 months in free-living high-risk subjects.

Methods: 772 high-risk subjects (age 69±5 years) were assigned to a low-fat diet or two Mediterranean-style diets. All participants received behavioural and nutritional education, including recommendations for increasing the consumption of vegetables, fruits, and legumes. Changes in food and nutrient intake, body weight, blood pressure, lipid profiles, glucose control and inflammatory markers were evaluated.

Results: Most participants increased consumption of vegetable products, but the increase in dietary fibre exhibited wide between-subject variability (6–65 g/day). Body weight, waist circumference, and mean systolic and diastolic blood pressure decreased across quintiles of fibre intake (p<0.005; all). Reductions in fasting glucose and total cholesterol levels, and increments in HDL cholesterol were highest among participants in the upper 20% of fibre intake (p = 0.04 and 0.02 respectively). Plasma concentrations of C-reactive protein, but not those of inflammatory cytokines, decreased in parallel with increasing dietary fibre (p = 0.04). Significant reductions in LDL cholesterol were observed only among participants with the greatest increases in soluble fibre intake (p = 0.04).

Conclusions: Increasing dietary fibre intake with natural foods is associated with reductions in classical and novel cardiovascular risk factors in a high-risk cohort.

Statistics from

The Mediterranean diet (Med-diet) has been widely considered as a model of healthy eating. This dietary pattern is characterised by a high consumption of non-refined grains, legumes, nuts, fruits and vegetables; relatively high intake of total fat, mainly derived from olive oil; moderate to high intake of fish and poultry; dairy products (usually as yogurt or cheese) in small amounts; low consumption of red meat and meat products; and moderate alcohol intake, usually in the form of red wine with meals.1 Thus, high consumption of fibre-rich foods is one of the characteristic features of the Med-diet.

Dietary fibre (DF), a mixture of chemicals in indigestible vegetable residues,2 has received much attention in nutritional epidemiology. Observational studies have consistently shown that DF intake is associated with reduced cardiovascular risk, including ischaemic heart disease36 and stroke,58 and lower risk of diabetes.911 Clinical trials have also suggested that DF supplementation has beneficial effects on risk factors, such as blood pressure, serum lipids, insulin sensitivity and diabetic metabolic control.1216 However, no intervention study has evaluated the effects of DF on classical and novel risk factors in free-living persons at high cardiovascular risk.

To address this issue, the effects of 3-month changes in DF intake on cardiovascular risk factors were evaluated in a large sample of subjects at high risk for cardiovascular disease.


Study design

The PREDIMED study (PREvención con DIeta MEDiterránea) is a large multi-centre, randomised 5-year clinical trial aimed at assessing the effects of the Med-diet on the primary prevention of cardiovascular disease (CVD) in Spain ( Up to September 2008, this trial includes 6988 high-risk participants allocated to three interventions: Med-diet plus virgin oil, Med-diet plus nuts and control diet (low-fat diet). The main outcome for the whole trial is an aggregate of cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke). The Institutional Review Boards of the participating centres approved the study protocol. This trial has been registered with the International Standard Randomised Controlled Trial Number (ISRCTN) 35739639. The trial design has been described in detail elsewhere.17

The present study was designed as a short-term trial in a subset of participants, namely those entering the PREDIMED trial during the first 6 months of recruitment, to assess the effects of changes in dietary fibre intake on surrogate markers of atherosclerosis.

Participants and recruitment

Nine-hundred and thirty possible participants were evaluated. Eligible subjects were community-dwelling persons, aged 55–80 years for men and 60–80 years for women, who had either type 2 diabetes or three or more of the following CHD risk factors: current smoking, hypertension (blood pressure>140/90 mmHg), LDL cholesterol ⩾160 mg/dl, low HDL cholesterol (⩽40 mg/dl), body mass index (BMI⩾25 kg/m2), or family history of premature CHD. Exclusion criteria were: previous history of cardiovascular disease, any severe chronic illness, illegal drug use or alcoholism, and low predicted likelihood of changing dietary habits.18

The primary care physicians based participants’ eligibility on review of clinical records and a screening visit. Suitable candidates were invited to attend a screening visit. This included a face-to-face interview to inquire about medical conditions and risk factors related to eligibility. More than 95% of eligible candidates who met entry requirements signed an informed consent and agreed to return for the baseline visit.

Baseline assessment and intervention

A validated 137-item food frequency questionnaire (FFQ),19 and the validated Spanish version20 of the Minnesota Leisure Time Physical Activity questionnaire were administered in the baseline assessment. For each food included in the FFQ, a standard portion size (representing the serving size of that item most frequently consumed currently in Spain) was specified. Dietary fibre intake was calculated by multiplying the frequency of consumption of each item by the fibre content of the specified serving, according to Spanish food composition tables.21 The intra-class correlation coefficient comparing DF intake by FFQ with the average of four 3-day dietary records was 0.75. Anthropometric measurements, blood pressure, spot urine and fasting blood samples were obtained. All examinations were repeated at 3 months.

Trained dieticians were responsible for all aspects of the interventions and assisted participants in completing the FFQ.22 Participants assigned to the control group received personal advice together with a leaflet with written recommendations to follow a low-fat diet.23 Participants in the two Med-diet intervention groups were given personalized advice for dietary changes directed to achieve a diet closest to the traditional Med-diet.22 Depending on group assignment, participants were given free virgin olive oil or free sachets of walnuts, hazelnuts and almonds. In the three groups, the general guidelines included positive recommendations for increased consumption of vegetables, fruits, legumes, fish and seafood, and white meats instead of red meats. Negative recommendations included limiting and/or eliminating presumed detrimental foods (red and processed meats, fat-rich dairy products, commercial pastries, snacks and sugar-sweetened beverages). Thus, all intervention diets coincided in the recommendation to increase fibre-rich foods, a reason why the three intervention groups are grouped as a single one for the comparisons of fibre intake and change in risk factor levels.

A 1-hour group session with up to 20 participants, with separate sessions for each intervention group, was scheduled after inclusion. Group sessions consisted of informative talks and provision of written material with descriptions of main foods, seasonal shopping lists, meal plans and cooking recipes.22


Weight and height were measured with calibrated scales and a wall-mounted stadiometer respectively. Waist circumference was measured midway between the lowest rib and the iliac crest using an anthropometric tape. Trained personnel measured blood pressure in triplicate with a validated semi-automatic oscillometer (Omron HEM-705CP, The Netherlands).

Blood and urine samples were obtained after an overnight fast. Serum, EDTA- plasma, and urine samples were coded, shipped to central laboratories and stored at −80°C until assay. The clinical investigators and laboratory technicians were blinded to intervention. Analyses determined by subject in frozen samples of whole serum or plasma as appropriate were: blood glucose by the glucose-oxidase method; serum insulin by radioimmunoassay; cholesterol and triglycerides by enzymatic procedures; HDL cholesterol after precipitation with phosphotungstic acid and magnesium chloride; soluble intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and interleukin-6 (IL-6) by standard ELISA assays; and high sensitivity C-reactive protein (CRP) by particle-enhanced immunonephelometry.

Statistical analyses

For the comparison of changes in risk factors, the average of two baseline measurements was used as the baseline value and the average of the two 3-month measurements was used as the final variable. Values with a skewed distribution (CRP, VCAM-1, ICAM-1 and IL-6) were transformed to their natural logarithm for analyses. Those subjects whose energy intake, as derived from food frequency questionnaires, was outside pre-specified ranges (2510–14 644 kJ for women and 3347–17 573 kJ for men) were excluded from the calculations of energy and nutrient intake, as recommended in nutritional epidemiology.24 Multiple linear regression models were used to study the relationship between DF and changes in risk factors. Mean differences in the changes of these variables (post-trial minus pre-trial values) were compared by quintiles of change in DF intake. Adjustments were made for intervention group, age, gender, body weight, smoking, alcohol intake and physical activity. The treatment effects are expressed as average changes and 95% confidence intervals (CI).


Of the 930 eligible subjects, 158 were excluded for the following reasons: not meeting inclusion criteria (n = 86), not accepting to change their dietary habits (n = 18), excessive alcohol intake (n = 14), gastrointestinal disease (n = 4), food allergies (n = 3) or refusing to participate (n = 33). Table 1 shows the baseline characteristics of the 772 participants (348 men and 424 women) who entered the study. Most of them were overweight or obese (90%), more than three-quarters had hypertension, one-quarter had family history of cardiovascular disease and one-fifth were smokers. There were only three withdrawals before study completion. The baseline data of these subjects were similar to the mean values for the overall group. Subsequent data refer only to the 769 participants who completed the study.

Table 1 Baseline characteristics of the 772 subjects included in the study

Food, energy and nutrient intake

Forty-eight participants were excluded from food, energy and nutrient calculations because they reported unrealistic energy intakes.21 Following the advice of the dieticians, most of the participants increased consumption of vegetables, legumes, fruits and fish, and decreased intake of meat and dairy products (table 2). Cereal intake also decreased due to reduced consumption of white bread, which is the main cereal food in the Spanish diet. A large increase in the consumption of nuts, one of the supplemental foods given, was observed, whereas the total amount of olive oil did not change because participants replaced customarily used refined olive oil by the virgin variety supplied. Alcohol intake increased slightly at the expense of wine, one of the components of the Med-diet recommended in moderation to participants who were not abstainers at baseline. The results did not materially change when the participants whose energy consumption was out of range were included in the calculations.

Table 2 Baseline levels and 3-month changes in the consumption of key food items, energy and nutrients

Table 2 also shows 3-month changes in energy and nutrient intake. The reduction from baseline in reported energy intake was due to decreases in intake of carbohydrate and total fat, whereas protein intake increased. Increases in intake of monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), including both vegetable and marine n-3 fatty acids, and a decrease in saturated fatty acid (SFA) intake occurred. Estimated energy expenditure from physical activity was similar at baseline and after 3 months.

Fibre and vascular risk factors

A significant increase in total and soluble DF intake was observed at the 3-month assessment (table 2). However, the consumption of DF exhibited wide between-subject variability. In fact, daily DF intake ranged from 6 to 65 g at the 3-month assessment. Because energy and DF intake increased in parallel, changes in DF intake categorised in quintiles were energy-adjusted to assess associations with other variables (table 3). Demographic characteristics, adiposity and cardiovascular risk factors were similar across the range of DF intake. Predictably, increasing DF intake was associated directly with carbohydrate intake and inversely with intake of total fat, MUFA and SFA. There were no differences in alcohol intake or sedentariness by categories of DF intake.

Table 3 Subjects’ characteristics and energy and nutrient intake according to quintiles of energy-adjusted dietary fibre intake at 3 months

Table 4 shows adjusted changes in risk factors according to quintiles of change in DF. The higher the increment in DF intake, the greater was the weight loss and the reduction in waist circumference and systolic and diastolic blood pressure. In addition, fasting glucose and total cholesterol levels decreased, and HDL cholesterol increased with increasing DF intake. Reductions in serum LDL cholesterol concentrations, but not in triglycerides, were not significantly higher for participants with greater increases in DF. The plasma levels of CRP, a systemic biomarker of inflammation, but not those of other inflammatory biomarkers, also decreased in parallel with increases in DF.

Table 4 Three-month changes in risk factors by quintiles of change in dietary fibre intake

Table 5 shows changes in cardiovascular risk factors between extreme quintiles of DF intake. The differences were statistically significant for body weight, waist circumference, systolic and diastolic blood pressure, fasting glucose and total cholesterol. When the same analysis was performed for changes in soluble DF intake, the results were similar, except for changes in LDL cholesterol, which were −8.06 mg/dl (95% CI 15.83 to −2.87), significantly (p = 0.042) different between extreme quintiles. Changes of cardiovascular risk factors in quintile 5 versus quintile 1 of DF intake ranged from nearly 1 kg reduction in body weight to close to a 9 mm decrease in systolic blood pressure.

Table 5 Mean changes (95% confidence intervals) and mean differences (95% confidence intervals) in changes in adiposity, blood pressure and other risk factors between the lowest (Q1) and the highest (Q5) quintile of changes in total dietary fibre intake


The hypothesis that the provision of increasing amounts of DF from natural foods might be instrumental in the effect of a Mediterranean-style diet to reduce the levels of cardiovascular risk factors was tested. The rationale underlying this substudy of the PREDIMED feeding trial was the available epidemiological and clinical trial evidence supporting the association of DF intake with beneficial effects on surrogate markers of cardiometabolic risk, including systemic inflammation.12 14 2527 In fact, DF intake after a 3-month behavioural intervention to enhance the Med-diet was associated with significant reductions in body weight, waist circumference, systolic and diastolic blood pressure and fasting glucose, as well as a greater increase in HDL cholesterol. In addition, when changes in the consumption of soluble DF were specifically assessed, participants in the highest quintile also showed a significantly greater reduction in serum LDL cholesterol concentration than those in the lowest quintile.

Many epidemiological studies have evaluated the effects of DF on the risk of coronary heart disease.36 In a pooled analysis of 10 prospective cohorts,28 each 10-g/day increment of energy-adjusted total DF was associated with a 14% decrease in risk of coronary events and a 27% decrease in risk of coronary death. However, in the only randomised clinical trial designed to examine whether increased intake of DF reduces the risk of myocardial infarction, the DART study,29 patients with existing coronary heart disease advised to increase DF did not have lower reinfarction rates over a 2-year period. Furthermore, DF advice had no clear effect on coronary or all-cause mortality after longer follow-up.30 Most likely, as assessed in prospective studies,28 DF intake with the usual diet is a marker of healthy food choices with an overall cardiovascular benefit, whereas changing the diet to increase DF at late stages, when clinical consequences of atherosclerosis have developed, may not be protective, as has been shown in a similar situation for antioxidant supplements as opposed to the antioxidant content of the habitual diet.31 Indeed, a plant-based diet is rich in both fibre and antioxidants. At any rate, increasing DF during 3 months by older individuals at high cardiovascular risk has measurable beneficial effects on several risk factors.

Reduced adiposity, particularly in the highest category of DF intake (tables 4 and 5), was observed in the present study. Large prospective studies have reported that consumption of DF is inversely associated with weight.3234 A high intake of DF may assist weight loss because of the incomplete digestion and absorption of energy from this type of carbohydrate and the bulky nature of high-fibre foods, with increased demands on chewing and subsequent distension and delayed emptying of the stomach, promoting satiety and thus curtailing energy intake.25 26 35 The present results further support a beneficial role of fibre-rich diets on weight control.

Increasing DF intake was associated with significant blood pressure lowering in those mostly hypertensive participants. Consistently, large prospective studies have reported that increased DF was associated with lower risk of hypertension36 or lower self-reported blood pressure.37 A meta-analysis of clinical studies of fibre supplementation12 also supports an inverse association between fibre and blood pressure. Accordingly, an increase in DF has been recommended by the World Health Organization as a safe and practical approach to cardiovascular risk reduction in hypertensive populations.38

Participants who increased DF intake also showed a reduction in fasting glucose levels, extending previous observations of the favourable effects of a diet with abundant fibre-rich foods, particularly whole grain, bran and germ intake, on the risk of type 2 diabetes.911 39 40 Dietary fibre reduces the glycaemic index of foods, thereby attenuating insulin responses and enhancing insulin sensitivity,41 42 to which associated weight loss is likely to contribute.

Structural fibre is insoluble, whereas natural gel-forming fibres are soluble,2 and increasing consumption of this particular variety of DF has a modest cholesterol-lowering effect that is attributable to interference with intestinal bile acid absorption and enhancement of faecal cholesterol excretion, although other mechanisms can be operative.42 Thus, increasing soluble fibre intake by 1 g/day is associated with a mean reduction in serum LDL cholesterol level of about 2 mg/dl (0.052 mmol/l), according to a meta-analysis of randomised trials of soluble fibre supplementation.13 In support of these evidences, the present study shows a significant −8.06 mg/dl LDL cholesterol decrease between extreme quintiles of soluble fibre intake.

As atherosclerosis is considered a low-grade inflammatory disease,43 the relationship between DF intake and serum inflammatory markers has also been evaluated in epidemiological and clinical studies, as reviewed.2527 Results from recent epidemiological studies have consistently shown an inverse association between DF intake and plasma CRP levels.4447 In a recent study, both increasing fibre intake by about 30 g/day from a diet naturally rich in fibre or from a supplement reduced levels of CRP.48 Thus, it was not surprising that a nearly 1 mg/L reduction in CRP levels was observed in the upper quintile of energy-adjusted DF intake (⩽26 g/day), after adjustment for sex, age, BMI and relevant lifestyle characteristics. However, no changes were observed in other inflammatory biomarkers. The mechanisms of change in CRP levels as a result of DF intake are still largely unknown. Possibilities include DF slowing absorption of glucose, fibre-rich meal modulation of cytokine responses blunting oxidative stress and inflammation, and production of anti-inflammatory cytokines by gut flora exposed to fibre.26 27

The present study has limitations. As no biomarker of DF intake is available, FFQ data were the only source of information on food consumption, including DF. Food frequency questionnaires are known to contain measurement errors, a reason why energy intake was included as a covariate in the models to achieve the equivalent of an isoenergetic diet and thus overcome this problem. At any rate, measurement error most likely would have introduced non-differential misclassification, and the implications for the results of this error would have been to bias the estimates towards the null. The duration of follow-up lasting only 3 months cannot be considered a major limitation, because the effects of dietary interventions on risk factors do not need a long induction period.49 The study also has strengths, such as reproducing real-life conditions with home-prepared foods in free-living individuals, as in usual clinical practice. Other strengths are the high response and low drop-out rates, which can be partly explained because participants belonged to a Mediterranean culture in which people are accustomed to using olive oil and nuts and enjoy eating fibre-rich vegetables, fruits and legumes, and the supplemental foods were provided at no cost.

In summary, the results of this study show that an increase in DF intake achieved with natural foods in the setting of a Mediterranean-style diet can reduce cardiovascular risk factors. Except for subjects in the highest 20% of DF intake, the effects on each individual risk factor were modest but, taken together, they suggest that increasing DF consumption may be instrumental in modifying the population cardiovascular risk profile, therefore preventing or delaying future cardiovascular events.

What is already known on this subject

  • Epidemiological studies have suggested that dietary fibre intake is associated with reduced incidence of ischaemic heart disease, stroke and diabetes.

  • Clinical trials have also pointed out that diets with fibre supplementation may reduce blood pressure, improve lipid profile and increase insulin sensitivity.

  • No intervention studies have evaluated the effects of dietary fibre on classical and novel risk factors in free-living subjects at high cardiovascular risk.

What this study adds

  • The increase of dietary fibre in an intervention aimed to upgrade consumption of fruits, vegetables and legumes in the setting of a Mediterranean-style diet was associated with reductions in cardiovascular risk factors, such as body weight, waist circumference, systolic and diastolic blood pressures, serum glucose and C-reactive protein.

  • Reductions in total cholesterol and LDL cholesterol were observed only among participants with greater increases in soluble fibre intake.

  • These beneficial effects on surrogate markers of cardiovascular risk add biological plausibility to the epidemiological evidence supporting a protective effect of dietary fibre intake on the risk for cardiovascular diseases.


We thank the participants for their enthusiastic collaboration and all the PREDIMED personnel for excellent assistance with all aspects of the trial. The authors are grateful to grant support by the Spanish Minister of Health (RTIC G03/140 and RD06/0045), the FIS 070473, Centro Nacional de Investigaciones Cardiovasculares (CNIC06) and MADAUS Pharm for their collaboration in the study. Emili Corbella provided expert assistance with statistical analyses. CIBEROBN is an initiative of Instituto de Salud Carlos III, Spain.


View Abstract


  • Competing interests: None.

  • Funding: Grant support by the Spanish Minister of Health (RTIC G03/140 and RD06/0045), the FIS 070473, Centro Nacional de Investigaciones Cardiovasculares (CNIC06) and MADAUS Pharm.

  • Ethics approval: The Institutional Review Boards of the participating centres approved the study protocol (eg Hospital Clinic, Barcelona, Spain, as the coordinating centre).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.